Evidence map›Paper›PMID 30188891›Full record

Observational studyPLoS neglected tropical diseases2018

Improving systematic rabies surveillance in Cameroon: A pilot initiative and results for 2014-2016.

Casimir Ledoux Sofeu, Anaïs Broban, Amadou Njifou Njimah, Jean Blaise Momo, Serge Alain Sadeuh-Mba, Sophie Druelles, Maïna L'Azou, Mathurin Cyrille Tejiokem

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Casimir Ledoux SofeuEpidemiology and Public Health Service, Centre Pasteur du Cameroun, Member of the International Network of Pasteur Institutes, Yaoundé, Cameroon.
Anaïs BrobanGlobal Epidemiology, Sanofi Pasteur, Istanbul, Turkey.
Amadou Njifou NjimahMbouda Health District Hospital, West Regional Delegation of Public Health, Ministry of Public Health, Bafoussam, Cameroon.
Jean Blaise MomoVirology Service, Centre Pasteur du Cameroun, Member of the International Network of Pasteur Institutes, Yaoundé, Cameroon.
Serge Alain Sadeuh-MbaVirology Service, Centre Pasteur du Cameroun, Member of the International Network of Pasteur Institutes, Yaoundé, Cameroon.
Sophie DruellesGlobal Epidemiology, Sanofi Pasteur, Lyon, France.
Maïna L'AzouGlobal Epidemiology, Sanofi Pasteur, Lyon, France.ORCID 0000-0001-7753-0630
Mathurin Cyrille TejiokemEpidemiology and Public Health Service, Centre Pasteur du Cameroun, Member of the International Network of Pasteur Institutes, Yaoundé, Cameroon.
Centre Pasteur du Cameroun · CMSanofi (France) · FRSanofi (Turkey) · TRUniversity of Douala · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine rabies is endemic in Cameroon, but human rabies exposures and cases are likely underreported because of inadequate surveillance. In 2014, the surveillance network in the West region of Cameroon was reinforced by introducing a new anti-rabies center, a framework for data collection and evaluation, provisions for sample collecting and laboratory confirmation, and training for health professionals. The objective of this observational cohort study was to describe the incidence and characteristics of reported exposures and human and animal rabies cases following this reinforcement of the existing rabies surveillance system. The surveillance network consisted of local, regional, and national health and veterinary authorities in 11 of the 20 West region districts, and was completely integrated within the existing national rabies surveillance network. Animal exposures and suspected rabies exposures, the suspected rabid animals involved, and laboratory confirmation of human and animal rabies cases were recorded in a centralized information database. Between January 2014 and June 2016, the network recorded 1340 animal exposure cases for an overall incidence rate of 38.2 animal exposures per 100,000 people, four confirmed rabies-positive animals, and one confirmed human rabies case out of four clinically suspected cases. In contrast, 62 animal exposures and an overall incidence rate of 6.1 exposures per 100,000 people were reported for the West region districts not participating in the reinforced surveillance. Of the 925 animal exposure victims for whom a detailed case report form was completed, 703 were considered to be at risk of rabies and only 428 (61%) of these received any post-exposure prophylaxis in the form of rabies vaccine. Obstacles encountered within the network included low rates of animal sample submission and animal follow-up by veterinarians. Reinforced rabies surveillance in the West region of Cameroon has provided the most accurate estimate of the region's disease and exposure burdens to date, and indicates that animal exposures are substantially underreported. The reinforced network also signaled that greater access to post-exposure prophylaxis is needed. Integration of regions not covered by the surveillance network and efforts to improve engagement of veterinary services will be needed to reveal the true burden of rabies in Cameroon.

Indexed as

Epidemiological MonitoringAdolescentAdultAnimal DiseasesAnimalsCameroonChildCommunicable Disease ControlFemaleHumansIncidenceMaleProspective StudiesRabiesYoung AdultZoonoses

Identifiers

PMID30188891
PMCPMC6126802
OpenAlexW2889840318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.